467 related articles for article (PubMed ID: 2411794)
21. Quantitative and qualitative differences in HLA-DR molecules correlated with antigen-presentation capacity.
Bontrop R; Ottenhoff T; Van Miltenburg R; Elferink D; De Vries R; Giphart M
Eur J Immunol; 1986 Feb; 16(2):133-8. PubMed ID: 3485528
[TBL] [Abstract][Full Text] [Related]
22. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
23. Graft-versus-host disease associated T helper cell responses specific for minor histocompatibility antigens are mainly restricted by HLA-DR molecules.
van Els CA; Zantvoort E; Jacobs N; Bakker A; van Rood JJ; Goulmy E
Bone Marrow Transplant; 1990 Jun; 5(6):365-72. PubMed ID: 2142441
[TBL] [Abstract][Full Text] [Related]
24. A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.
Nagvekar N; Moody AM; Moss P; Roxanis I; Curnow J; Beeson D; Pantic N; Newsom-Davis J; Vincent A; Willcox N
J Clin Invest; 1998 May; 101(10):2268-77. PubMed ID: 9593783
[TBL] [Abstract][Full Text] [Related]
25. Suppression by mAbs against DQB1 peptides of in vitro proliferation of AChR-specific T cells from myasthenia gravis patients.
Oshima M; Ohtani M; Deitiker PR; Smith RG; Mosier DR; Atassi MZ
Autoimmunity; 2005 Mar; 38(2):161-9. PubMed ID: 16040337
[TBL] [Abstract][Full Text] [Related]
26. Specificity of the T cell immune response to acetylcholine receptor in experimental autoimmune myasthenia gravis. Response to subunits and synthetic peptides.
Fujii Y; Lindstrom J
J Immunol; 1988 Mar; 140(6):1830-7. PubMed ID: 2450133
[TBL] [Abstract][Full Text] [Related]
27. Peptide-selected T cell lines from myasthenia gravis patients and controls recognize epitopes that are not processed from whole acetylcholine receptor.
Matsuo H; Batocchi AP; Hawke S; Nicolle M; Jacobson L; Vincent A; Newsom-Davis J; Willcox N
J Immunol; 1995 Oct; 155(7):3683-92. PubMed ID: 7561069
[TBL] [Abstract][Full Text] [Related]
28. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
Yamamoto M; Yano A
J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
[TBL] [Abstract][Full Text] [Related]
29. Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice.
Yang H; Goluszko E; David C; Okita DK; Conti-Fine B; Chan TS; Poussin MA; Christadoss P
J Clin Invest; 2002 Apr; 109(8):1111-20. PubMed ID: 11956249
[TBL] [Abstract][Full Text] [Related]
30. Human acetylcholine receptor presentation in myasthenia gravis. DR restriction of autoimmune T epitopes and binding of synthetic receptor sequences to DR molecules.
Manfredi AA; Yuen MH; Moiola L; Protti MP; Conti-Tronconi BM
J Immunol; 1994 Apr; 152(8):4165-74. PubMed ID: 7511671
[TBL] [Abstract][Full Text] [Related]
31. Differential regulatory role of monomorphic and polymorphic determinants of histocompatibility leukocyte antigen class I antigens in monoclonal antibody OKT3-induced T cell proliferation.
De Felice M; Turco MC; Giarrusso PC; Corbo L; Pizzano R; Martinelli V; Ferrone S; Venuta S
J Immunol; 1987 Oct; 139(8):2683-9. PubMed ID: 2443568
[TBL] [Abstract][Full Text] [Related]
32. Myasthenia gravis. Residues of the alpha and gamma subunits of muscle acetylcholine receptor involved in formation of immunodominant CD4+ epitopes.
Moiola L; Protti MP; McCormick D; Howard JF; Conti-Tronconi BM
J Immunol; 1994 May; 152(9):4686-98. PubMed ID: 7908921
[TBL] [Abstract][Full Text] [Related]
33. Binding of a major T cell epitope of mycobacteria to a specific pocket within HLA-DRw17(DR3) molecules.
Geluk A; Bloemhoff W; De Vries RR; Ottenhoff TH
Eur J Immunol; 1992 Jan; 22(1):107-13. PubMed ID: 1370411
[TBL] [Abstract][Full Text] [Related]
34. Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene.
Melms A; Chrestel S; Schalke BC; Wekerle H; Mauron A; Ballivet M; Barkas T
J Clin Invest; 1989 Mar; 83(3):785-90. PubMed ID: 2466050
[TBL] [Abstract][Full Text] [Related]
35. T cell responses to human recombinant acetylcholine receptor-alpha subunit in myasthenia gravis and controls.
Sun JB; Harcourt G; Wang ZY; Hawke S; Olsson T; Fredrikson S; Link H
Eur J Immunol; 1992 Jun; 22(6):1553-9. PubMed ID: 1376263
[TBL] [Abstract][Full Text] [Related]
36. Use of Torpedo-mouse hybrid acetylcholine receptors reveals immunodominance of the alpha subunit in myasthenia gravis antisera.
Loutrari H; Tzartos SJ; Claudio T
Eur J Immunol; 1992 Nov; 22(11):2949-56. PubMed ID: 1385157
[TBL] [Abstract][Full Text] [Related]
37. A juxta-membrane epitope on the human acetylcholine receptor recognized by T cells in myasthenia gravis.
Harcourt GC; Sommer N; Rothbard J; Willcox HN; Newsom-Davis J
J Clin Invest; 1988 Oct; 82(4):1295-300. PubMed ID: 2459161
[TBL] [Abstract][Full Text] [Related]
38. Schwann cells and myasthenia gravis. Preferential uptake of soluble and membrane-bound AChR by normal and immortalized Schwann cells, and immunogenic presentation to AChR-specific T line lymphocytes.
Zhang YP; Porter S; Wekerle H
Am J Pathol; 1990 Jan; 136(1):111-22. PubMed ID: 1688688
[TBL] [Abstract][Full Text] [Related]
39. Differential presentation of HLA-DR, DQ, and DP restriction elements by interferon-gamma-treated dermal fibroblasts.
Maurer DH; Hanke JH; Mickelson E; Rich RR; Pollack MS
J Immunol; 1987 Aug; 139(3):715-23. PubMed ID: 3110281
[TBL] [Abstract][Full Text] [Related]
40. Oral administration of acetylcholine receptor: effects on experimental myasthenia gravis.
Okumura S; McIntosh K; Drachman DB
Ann Neurol; 1994 Nov; 36(5):704-13. PubMed ID: 7979216
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
